Mesenchymal Stem Cell Transplantation in Multiple Sclerosis

Por Cohen, Jeffrey A.
Publicado em 2013

Handbook of multiple sclerosis

Por Cohen, Jeffrey A., Rae-Grant, Alexander.
Publicado em 2012

Sphingosine 1-Phosphate Receptor Modulators in Multiple Sclerosis

Por Subei, Adnan M., Cohen, Jeffrey A.
Publicado no CNS Drugs (2015)

Considerations in the development of generic disease therapies for multiple sclerosis

Por Hua, Le H., Cohen, Jeffrey A.
Publicado no Neurol Clin Pract (2016)

Abstract: Effect of Botulinum Toxin Injection Intervals on the Irreversibility of Targeted Muscle Paralysis: An Electromyographic Study

Por Boonipat, Thanapoom, Cohen, Jeffrey A., Stotland, Mitchell
Publicado no Plast Reconstr Surg Glob Open (2016)

Restricted diffusion preceding gadolinium enhancement in large or tumefactive demyelinating lesions

Por Hyland, Megan, Bermel, Robert A., Cohen, Jeffrey A.
Publicado em 2013

Late Occurrence of PML in a Patient Treated for Lymphoma with Immunomodulatory Chemotherapies, Bendamustine, Rituximab, and Ibritumomab Tiuxetan

Por Lane, Michael A., Renga, Vijay, Pachner, Andrew R., Cohen, Jeffrey A.
Publicado no Case Rep Neurol Med (2015)

Vision and vision-related outcome measures in multiple sclerosis

Por Balcer, Laura J., Miller, David H., Reingold, Stephen C., Cohen, Jeffrey A.
Publicado no Brain (2015)

Early Tolerability and Safety of Fingolimod in Clinical Practice

Por Ontaneda, Daniel, Hara-Cleaver, Claire, Rudick, Richard A., Cohen, Jeffrey A., Bermel, Robert A.
Publicado em 2012

Improvement of internuclear ophthalmoparesis in multiple sclerosis with dalfampridine

Por Serra, Alessandro, Skelly, Margaret M., Jacobs, Jonathan B., Walker, Mark F., Cohen, Jeffrey A.
Publicado em 2014

Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis

Por Karlsson, Goeril, Francis, Gordon, Koren, Gideon, Heining, Peter, Zhang, Xiaoli, Cohen, Jeffrey A., Kappos, Ludwig, Collins, William
Publicado em 2014

Experience with Fingolimod in Clinical Practice

Por Hersh, Carrie M., Hara-Cleaver, Claire, Rudick, Richard A., Cohen, Jeffrey A., Bermel, Robert A., Ontaneda, Daniel
Publicado no Int J Neurosci (2014)

The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis

Por Auletta, Jeffery J, Bartholomew, Amelia M, Maziarz, Richard T, Deans, Robert J, Miller, Robert H, Lazarus, Hillard M, Cohen, Jeffrey A
Publicado em 2012

Fingolimod versus intramuscular interferon in patient subgroups from TRANSFORMS

Por Cohen, Jeffrey A., Barkhof, Frederik, Comi, Giancarlo, Izquierdo, Guillermo, Khatri, Bhupendra, Montalban, Xavier, Pelletier, Jean, Eckert, Benjamin, Häring, Dieter A., Francis, Gordon
Publicado em 2013

The challenge of comorbidity in clinical trials for multiple sclerosis

Por Marrie, Ruth Ann, Miller, Aaron, Sormani, Maria Pia, Thompson, Alan, Waubant, Emmanuelle, Trojano, Maria, O'Connor, Paul, Reingold, Stephen, Cohen, Jeffrey A.
Publicado no Neurology (2016)

Efficacy of thalidomide for the treatment of amyotrophic lateral sclerosis: A phase II open label clinical trial

Por STOMMEL, ELIJAH W., COHEN, JEFFREY A., FADUL, CAMILO E., COGBILL, CHRISTOPHER H., GRABER, DAVID J., KINGMAN, LINDA, MACKENZIE, TODD, SMITH, JACQUELINE Y. CHANNON, HARRIS, BRENT T.
Publicado em 2009

Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis

Por Radue, Ernst-Wilhelm, Barkhof, Frederik, Kappos, Ludwig, Sprenger, Till, Häring, Dieter A., de Vera, Ana, von Rosenstiel, Philipp, Bright, Jeremy R., Francis, Gordon, Cohen, Jeffrey A.
Publicado no Neurology (2015)

Recommendations for observational studies of comorbidity in multiple sclerosis

Por Marrie, Ruth Ann, Miller, Aaron, Sormani, Maria Pia, Thompson, Alan, Waubant, Emmanuelle, Trojano, Maria, O'Connor, Paul, Fiest, Kirsten, Reider, Nadia, Reingold, Stephen, Cohen, Jeffrey A.
Publicado no Neurology (2016)

Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study

Por Cohen, Jeffrey A, Khatri, Bhupendra, Barkhof, Frederik, Comi, Giancarlo, Hartung, Hans-Peter, Montalban, Xavier, Pelletier, Jean, Stites, Tracy, Ritter, Shannon, von Rosenstiel, Philipp, Tomic, Davorka, Kappos, Ludwig
Publicado no J Neurol Neurosurg Psychiatry (2016)

Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients

Por Giovannoni, Gavin, Cohen, Jeffrey A., Coles, Alasdair J., Hartung, Hans-Peter, Havrdova, Eva, Selmaj, Krzysztof W., Margolin, David H., Lake, Stephen L., Kaup, Susan M., Panzara, Michael A., Compston, D. Alastair S.
Publicado no Neurology (2016)